{"slug":"all","tag":"all","variants":["all"],"description":"No description yet","count":5,"kinds":{"person":5},"related":[{"slug":"paediatric","tag":"paediatric","shared":3},{"slug":"cooperative-group","tag":"cooperative-group","shared":2},{"slug":"immunotherapy","tag":"immunotherapy","shared":2},{"slug":"chemo-free","tag":"chemo-free","shared":1},{"slug":"mrd","tag":"mrd","shared":1},{"slug":"st-jude","tag":"st-jude","shared":1}],"records":[{"id":"stephen-hunger","kind":"person","name":"Stephen P. Hunger","route":"/people/stephen-hunger/","tldr":"Chaired the COG leukaemia committee through the era that pushed childhood ALL cure rates above 90%."},{"id":"ching-hon-pui","kind":"person","name":"Ching-Hon Pui","route":"/people/ching-hon-pui/","tldr":"Led the St. Jude Total Therapy studies that cure over 90% of children with leukaemia without cranial radiation."},{"id":"sumit-gupta","kind":"person","name":"Sumit Gupta","route":"/people/sumit-gupta/","tldr":"Led COG AALL1731, which showed adding blinatumomab to chemotherapy improves survival for children with standard-risk leukaemia."},{"id":"elias-jabbour","kind":"person","name":"Elias Jabbour","route":"/people/elias-jabbour/","tldr":"Leukaemia specialist who built chemotherapy-light regimens combining inotuzumab, blinatumomab and ponatinib for adult ALL."},{"id":"nicola-gokbuget","kind":"person","name":"Nicola Gökbuget","route":"/people/nicola-gokbuget/","tldr":"Leads the German GMALL group and showed blinatumomab clears residual leukaemia in adults with ALL."}]}